Skip to main content

Table 4 Causes of death

From: Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

  No-ATG ATG
N = 144 N = 35
Relapse 77 (53.5%) 19 (54.3%)
GVHD 32 (22.2%) 6 (17.1%)
Infection 23 (16%) 5 (14.3%)
VOD 5 (3.5%) 3 (8.6%)
Idiopathic pneumonia 2 (1.4%) 0 (0%)
Hemorrhage 2 (1.4%) 0 (0%)
Other SCT-related 3 (2.1%) 2 (5.7%)
  1. ATG anti-thymocyte globulin, GVHD graft-versus-host disease, SCT stem cell transplantation, VOD veno-occlusive disease